3-71772812-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001126128.2(PROK2):c.302G>A(p.Arg101Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000177 in 1,613,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001126128.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROK2 | NM_001126128.2 | c.302G>A | p.Arg101Gln | missense_variant | 4/4 | ENST00000295619.4 | NP_001119600.1 | |
PROK2 | NM_021935.4 | c.239G>A | p.Arg80Gln | missense_variant | 3/3 | NP_068754.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROK2 | ENST00000295619.4 | c.302G>A | p.Arg101Gln | missense_variant | 4/4 | 1 | NM_001126128.2 | ENSP00000295619.3 | ||
PROK2 | ENST00000353065.7 | c.239G>A | p.Arg80Gln | missense_variant | 3/3 | 1 | ENSP00000295618.3 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152106Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251264Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135816
GnomAD4 exome AF: 0.000177 AC: 259AN: 1461804Hom.: 0 Cov.: 31 AF XY: 0.000179 AC XY: 130AN XY: 727210
GnomAD4 genome AF: 0.000178 AC: 27AN: 152106Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74308
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 08, 2022 | This variant is present in population databases (rs376839931, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 101 of the PROK2 protein (p.Arg101Gln). This variant has not been reported in the literature in individuals affected with PROK2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
PROK2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 18, 2024 | The PROK2 c.302G>A variant is predicted to result in the amino acid substitution p.Arg101Gln. This variant was reported in an individual with Kallman syndrome, but no further evidence was provided to establish its pathogenicity (Dodé and Rondard. 2013. PubMed ID: 23596439). This variant is reported in 0.025% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at